|
Index of reports
> Life Threatening Events (62)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 62 Next >>
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Renal Impairment, Vomiting, Nausea, Dizziness, General Physical Health Deterioration
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Glycyron
Dosage: 6 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-12
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-16
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Other drugs received by patient: Adalat CC; Olmesartan Medoxomil; Olmesartan Medoxomil; Loxonin; Loxonin; Adalat CC; Adalat CC; Glycyron; Doxazosin Mesylate; Metformin HCL; Kinedak; Adalat CC; Nesina; Loxonin; Potassium Chloride; Trichlormethiazide; Amaryl; Lendormin; Allopurinol; Trichlormethiazide; Vitamin E; Primperan TAB; Amaryl; Loxonin; Metformin HCL; Kinedak; Rohypnol; Doxazosin Mesylate; Nesina; Urso 250; Vitamin B12; Electrolytes (Unspecified) (+) Sodium Lactate; Lyrica; Lendormin D
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Renal Impairment, Vomiting, Nausea, General Physical Health Deterioration, Dizziness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Glycyron
Dosage: 6 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-12
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-16
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Other drugs received by patient: Nesina; Metformin HCL; Adalat CC; Doxazosin Mesylate; Amaryl; Amaryl; Kinedak; Allopurinol; Olmesartan Medoxomil; Trichlormethiazide; Loxonin; Primperan TAB; Adalat CC; Olmesartan Medoxomil; Vitamin B12; Loxonin; Doxazosin Mesylate; Kinedak; Loxonin; Loxonin; Potassium Chloride; Lyrica; Lendormin D; Adalat CC; Metformin HCL; Lendormin; Rohypnol; Electrolytes (Unspecified) (+) Sodium Lactate; Glycyron; Trichlormethiazide; Nesina; Urso 250; Vitamin E; Adalat CC
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Anaemia, Suicidal Ideation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 micrograms per 0.5 ml injection qw
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-08-03
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
End date: 2012-08-03
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
Other drugs received by patient: Oxycodone HCL; Clonazepam; Nicotine; Celexa; Neuroxin (Cyanocobalamin (+) Pyridoxine Hydrochloride (+) Thiamine HYD
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: daily dosage unknown
Indication: Hepatitis C
Start date: 2010-01-01
Rebetol
Dosage: daily dosage unknown
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-01-01
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-22
Patient:
Reactions: Pulmonary Embolism, Suicide Attempt, Depression, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Blinded Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
PEG-Intron
Dosage: 120 micrograms, qw
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-02-11
End date: 2011-01-06
Peginterferon Alfa-2B
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Placebo
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Rebetol
Dosage: 600 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-02-11
End date: 2011-01-07
Ribavirin
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Other drugs received by patient: Norvir; Zolpidem Tatrate; Reyataz; Xanax; Escitalopram Oxalate; Epivir; Imodium; Invirase
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Enanthema, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-29
End date: 2012-05-09
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-10
End date: 2012-05-29
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Start date: 2012-03-29
End date: 2012-05-29
PEG-Intron
Dosage: 1.5 microgram per kilogram, per week
Start date: 2012-03-29
End date: 2012-05-28
PEG-Intron
Dosage: unk
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-03-29
End date: 2012-04-18
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-02
End date: 2012-05-16
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-19
End date: 2012-05-01
Rebetol
Dosage: unk mg, once
Administration route: Oral
Start date: 2012-05-17
End date: 2012-05-28
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-10
End date: 2012-05-28
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Start date: 2012-03-29
End date: 2012-05-09
Other drugs received by patient: Myser (Difluprednate); Levocarnitine Hydrochloride; Myser (Cycloserine); Ferrous Sulfate TAB; Locoid; L Cartin; Ferrous Sulfate TAB; Locoid; Allopurinol; L Cartin; Myser (Difluprednate); Allegra; Talion (Bepotastine Besylate); Talion (Bepotastine Besylate); Allopurinol
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-08-15
Patient:
Reactions: Major Depression
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Start date: 2012-04-05
End date: 2012-05-30
Ribavirin
Dosage: 5 df, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-05
End date: 2012-05-30
Ribavirin
Dosage: 5 df, bid
Administration route: Oral
Start date: 2012-04-05
End date: 2012-05-30
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Anaemia, Suicidal Ideation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-08-03
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
End date: 2012-08-03
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-03
Patient:
Reactions: Subarachnoid Haemorrhage
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Start date: 2012-01-06
End date: 2012-04-19
PEG-Intron
Dosage: 80 ?g, qw
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-06
End date: 2012-04-19
Rebetol
Dosage: 600 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-06
End date: 2012-04-25
Other drugs received by patient: Loxoprofen; Allegra; Allegra; Teprenone; Teprenone
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient:
Reactions: Pneumonia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Rebetol
Victrelis
Possible PEG-Intron side effects in
Reported by a physician from Austria on 2012-07-30
Patient:
Reactions: Agranulocytosis, Anaemia, Platelet Count Decreased, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram, unk
Indication: Hepatitis C
Start date: 2012-03-21
End date: 2012-06-10
Rebetol
Dosage: unk
Indication: Hepatitis C
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-21
End date: 2012-06-10
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-29
Patient:
Reactions: Death
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Victrelis
Possible PEG-Intron side effects in
Reported by a physician from Germany on 2012-07-20
Patient:
Reactions: Vomiting, Renal Failure, Sepsis, Urinary Tract Infection, Hepatic Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: 1600 mg
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
PEG-Intron
Dosage: 180 micg, qw
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
Victrelis
Dosage: 3 x 800
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-19
Other drugs received by patient: Citalopram Hydrobromide; Haloperidol; Metoclopramide; Lercanidipine; Mirtazapin Stada; Ramipril
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Rebetol
Victrelis
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient:
Reactions: Pneumonia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Rebetol
Victrelis
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-07-12
Patient:
Reactions: Anaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1,5 ug/kg/week
Indication: Hepatitis C
Start date: 2012-03-30
End date: 2012-06-15
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-04
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-27
End date: 2012-05-03
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-30
End date: 2012-04-26
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
End date: 2012-06-15
Telaprevir
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-30
End date: 2012-06-15
Possible PEG-Intron side effects in
Reported by a physician from Germany on 2012-07-11
Patient:
Reactions: Vomiting, Renal Failure, Urinary Tract Infection, Hepatic Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: 1600 mg
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
PEG-Intron
Dosage: 180 micg, qw
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
Victrelis
Dosage: 3 x 800
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-19
Other drugs received by patient: Ramipril; Haloperidol; Metoclopramide; Lercanidipine; Mirtazapin Stada; Citalopram Hydrobromide
Possible PEG-Intron side effects in 37 year old female
Reported by a physician from Japan on 2012-07-05
Patient: 37 year old female, weighing 46.0 kg (101.2 pounds)
Reactions: Ruptured Cerebral Aneurysm, Subarachnoid Haemorrhage
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 mcg, qw, sc
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-06
End date: 2012-04-19
Rebetol
Dosage: 600 mg, bid, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-06
End date: 2012-04-25
Other drugs received by patient: Allegra; Loxoprofen; Teprenone
Possible PEG-Intron side effects in 37 year old female
Reported by a physician from Brazil on 2012-07-03
Patient: 37 year old female, weighing 66.3 kg (145.9 pounds)
Reactions: Anaemia, Pancytopenia, Fibromyalgia, Apparent Life Threatening Event, Depression, Acute Respiratory Failure, Septic Shock, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 mcg;qw;sc
Indication: Hepatitis C
Start date: 2012-03-16
End date: 2012-05-27
Ribavirin
Dosage: 500 mg;q12h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-16
End date: 2012-05-27
Victrelis
Dosage: 800 mcg;q8h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-05-27
Other drugs received by patient: Clonazepam; Sertraline Hydrochloride
Possible PEG-Intron side effects in 37 year old female
Reported by a physician from Germany on 2012-06-26
Patient: 37 year old female
Reactions: Renal Failure, Hepatic Failure
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Copegus
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-18
PEG-Intron
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-18
Victrelis
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-18
Other drugs received by patient: Ramipril; Mirtazapine; Citalopram Hydrobromide; Metoclopramide; Lercanidipine; Haloperidol
Possible PEG-Intron side effects in 51 year old male
Reported by a physician from Austria on 2012-06-19
Patient: 51 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Syncope, Brain Abscess, Epilepsy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-09
Ribavirin
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-09
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
End date: 2012-06-15
Possible PEG-Intron side effects in female
Reported by a physician from United States on 2012-06-12
Patient: female
Reactions: Overdose, Suicide Attempt
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Indication: Product Used FOR Unknown Indication
PEG-Intron
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Victrelis
Indication: Product Used FOR Unknown Indication
Possible PEG-Intron side effects in female
Reported by a pharmacist from United States on 2012-06-01
Patient: female, weighing 108.9 kg (239.5 pounds)
Reactions: Suicidal Ideation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150mcg once weekly sq
Indication: Hepatitis C
Start date: 2012-03-14
End date: 2012-05-31
Ribavirin
Dosage: 400mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-14
End date: 2012-05-31
Possible PEG-Intron side effects in 5 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-09
Patient: 5 year old male, weighing 32.5 kg (71.5 pounds)
Reactions: Renal Tubular Disorder, Dyskinesia, Disseminated Intravascular Coagulation, Petechiae, Hepatic Failure, Mental Status Changes, Coma, Headache, Pyrexia, Lactic Acidosis, Urine Output Increased, Generalised Oedema, Malaise, Acute Respiratory Distress Syndrome, Pulmonary Oedema, Electrolyte Imbalance, Vomiting, International Normalised Ratio Increased, Respiratory Distress, Tremor, Nephrogenic Diabetes Insipidus, Convulsion, Renal Failure, Product Packaging Issue, Mitochondrial Toxicity, Depressed Level of Consciousness, Rash Maculo-Papular, Multi-Organ Disorder, Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: 445 mg;once;rtl
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-07
Acetaminophen
Dosage: 400 mg;once ; 400 mg;once
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-07
Acetaminophen
Dosage: 400 mg;once ; 400 mg;once
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-07
PEG-Intron
Dosage: 64 mcg;sc
Indication: Hepatitis C
Start date: 2010-01-07
End date: 2010-01-07
Rebetol
Dosage: 240 mg;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-01-07
End date: 2010-01-07
Possible PEG-Intron side effects in 59 year old female
Reported by a pharmacist from United States on 2012-04-30
Patient: 59 year old female
Reactions: Nausea, Dehydration, Platelet Count Decreased, Hallucination, Delirium, Epistaxis, Diabetes Mellitus Inadequate Control
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Product Used FOR Unknown Indication
Ribasphere
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: ;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-01
Other drugs received by patient: Bupropion HCL; Seroquel; Diovan; Hydrochlorothiazide; Citalopram Hydrobromide; Novolog; Humulin R
Possible PEG-Intron side effects in male
Reported by a pharmacist from United States on 2012-04-18
Patient: male
Reactions: Back Pain, Pruritus, Nausea, DRY Skin, Discomfort, Fluid Retention
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150mcg weekly sq
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-03-28
Ribavirin
Dosage: 600 mg bid oral
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-03-28
Possible PEG-Intron side effects in 64 year old male
Reported by a physician from Japan on 2012-04-09
Patient: 64 year old male, weighing 64.0 kg (140.8 pounds)
Reactions: Blood Bilirubin Increased, Hepatic Necrosis, Blood Urea Increased, Alanine Aminotransferase Increased, Hepatic Failure, Haemodialysis, Blood Uric Acid Increased, Aspartate Aminotransferase Increased, Prothrombin Time Shortened, Blood Creatinine Increased, Bilirubin Conjugated Increased, Altered State of Consciousness, Decreased Appetite, Blood Glucose Increased
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 mcg;qw;sc
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-03-06
Rebetol
Dosage: 800 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-03-11
Telavic (Telaprevir) (Investigational Drug)
Dosage: 2250 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-03-11
Other drugs received by patient: Nexium; Urso 250; Magmitt; Actos; Portolac; Amaryl; Talion
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-04-06
Patient: 57 year old female
Reactions: Pulmonary Necrosis, Metabolic Acidosis, Continuous Haemodiafiltration, Hepatic Failure, Treatment Noncompliance, Lung Abscess, Ascites, Multi-Organ Failure, Renal Failure, Dialysis, Respiratory Failure, Pneumonia Staphylococcal, Skin Infection, Septic Shock, Immunosuppression
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Boceprevir (Sch-503034)
Dosage: 800 mg;tid
Indication: Hepatitis C
Start date: 2011-01-19
End date: 2012-01-30
PEG-Intron
Dosage: 100 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-01-19
End date: 2011-01-30
Ribavirin
Dosage: 400 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-01-19
End date: 2012-01-30
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05
Patient: 57 year old female
Reactions: Pneumonia, Staphylococcal Infection, Lung Infection, Escherichia Infection, Candidiasis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: qw
Indication: Hepatitis C
Start date: 2011-07-01
Ribavirin
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Victrelis
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Victrelis
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-01
End date: 2012-01-01
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02
Patient: 57 year old female
Reactions: Pneumonia, Staphylococcal Infection, Escherichia Infection, Candidiasis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: ;qw;
Indication: Hepatitis C
Start date: 2011-07-01
Ribavirin
Dosage: ;qd;po
Administration route: Oral
Indication: Hepatitis C
Victrelis
Dosage: ;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Victrelis
Dosage: ;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-01
End date: 2012-01-01
Page 1 Next >>
|
